Extracellular flux analyzers (Seahorse-type respirometry platforms) and Clark-type oxygen electrodes are standard tools for measuring BAM-15's effect on oxygen consumption rate (OCR) in cell-based and isolated mitochondria preparations. Researchers typically measure basal respiration, then introduce BAM-15 to assess the magnitude of uncoupled respiration (oxygen consumption not coupled to ATP synthesis), followed by oligomycin and electron transport chain inhibitor titrations to fully resolve the bioenergetic profile and confirm the proton transport mechanism.

Fluorescent potentiometric dyes (such as TMRM or JC-1) combined with flow cytometry or fluorescence microscopy are used to measure changes in mitochondrial membrane potential following BAM-15 exposure, allowing researchers to quantify the degree of proton gradient dissipation across a concentration range. These measurements are typically paired with parallel ATP level assays to characterise the relationship between membrane potential changes and downstream bioenergetic consequences in the specific cell model under study.

Comparative bioenergetics research has examined BAM-15 relative to other protonophore-class compounds, with particular research interest in selectivity profiles distinguishing effects on the mitochondrial inner membrane from effects on the plasma membrane. Such studies typically employ parallel OCR and membrane potential assays across multiple uncoupler compounds at matched concentrations, allowing researchers to characterise relative potency, selectivity windows, and structure-activity relationships within this compound class.